亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Afobazole Nanoparticles Formulation for Enhanced Therapeutics

技術優勢
Blood brain barrier permeabilityEnhanced effectiveness for protecting neurons from ischemic injuryPotential to treat various diseases of the CNS involving excessive neuronalactivity and inflammation
技術應用
Alzheimer's Therapeutics; drug
詳細技術說明
Our researchers have addressed this problem with a new formulation of the drug using nanoparticle technology. Specifically, this novel invention utilizes a nanoparticle carrier encapsulating afobazole to effectively improve blood brain barrierpermeability. The improved pharmacokinetics may be used to treat various diseases of the CNS involving excessive neuronal activity and inflammation. In vitro release studies were carried out to investigate the rate of drug release by thenanoparticle formulations. An initial burst release of the drug was observed, followed by a sustained release of the drug from the nanoparticleΓÇÖs polymer. In vitro experiments have also shown that the nanoparticle formation of the drug enhances the effectiveness of this drug for protecting neurons from ischemic injury.
*Abstract
A novel nanoparticle formulation of the drug afobazole. This invention can be used toimprove the treatment of various diseases of the Central Nervous System (CNS).
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備